The T-Series waste caps come in a number of bottle thread types and connect to 1/8in OD semi-rigid tubing without requiring additional fittings. The tubing pushes straight through the cap Luer ports to create a liquid- and vapour-tight seal. Other tubing sizes can be accommodated using a variety of adapters, without compromising the seal. A separate ¼in-28 UNF thread port allows connection of a vapour trap and breakthrough indicator unit.
An activated carbon vapour trap isolates any solvent fumes and prevents escape from the system during pressure venting. When the trap becomes saturated, an integrated indicator strip turns red, alerting staff to replace the trap to prevent unintentional vapour breakthrough.
The product’s design also prevents over pressurisation. As liquid is collected in the waste bottle, either under pressure or gravity feed, vapour is automatically vented to the trap to prevent explosions or injury.
Diba is based in Danbury, Connecticut, US.
Omnifit bottle cap traps harmful vapours
Integrated test strip indicates when to replace cap
You may also like
Trending Articles
You may also like
Manufacturing
ACG to invest $200m in US hard-shell capsule manufacturing
ACG will build its first US capsule manufacturing facility in Atlanta, Georgia, with dedicated gelatine and HPMC lines, creating more than 200 jobs and expanding its North American presence ahead of operations starting in early 2027
Manufacturing
Syngene International unveils dedicated peptide lab and automation upgrades to accelerate drug discovery
Syngene International has invested in a new peptide laboratory in Bengaluru and advanced automation at its Hyderabad site to enhance scalability, efficiency and data quality across drug discovery and development workflows
Manufacturing
Roquette opens pharmaceutical innovation centre in Brazil
The Health & Pharma Solutions facility in São Paolo offers state-of-the-art laboratories for customers, with the Northeast Center for Strategic Technologies partnering with Roquette to empower young women to pursue careers in science through the Futuras Cientistas programme at the facility
Manufacturing
Samsung Bioepis and Phrontline join forces to advance best-in-class antibody-drug conjugate therapeutics for solid tumours
The pair will co-develop two investigational ADC assets directed against targets expressed in a broad range of cancers, adding a new class of bispecific and dual-payload ADC therapeutics to Samsung Bioepis' oncology portfolio